Lutathera Approval Positions Novartis To Regain NET Share Taken By Ipsen

 
• By Eleanor Malone
  
Product life cycle
Lutathera approval may help Novartis manage Sandostatin's market decline • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip